Li Z. Xuan

No.1838 North Guangzhou Avenue
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study.

Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study.

Journal: Experimental hematology & oncology

Published: March 25, 2026

Donor-derived distinct neutrophil subsets in the G-CSF-mobilized peripheral blood grafts predict acute GVHD development.

Donor-derived distinct neutrophil subsets in the G-CSF-mobilized peripheral blood grafts predict acute GVHD development.

Journal: Transplantation and cellular therapy

Published: March 11, 2026

Impact of Concurrent Genetic Alterations on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Impact of Concurrent Genetic Alterations on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Journal: Cancer letters

Published: January 31, 2026

Activation of c-Myc confers resistance to venetoclax via inhibition of Bim in t(8;21)-positive acute myeloid leukemia.

Activation of c-Myc confers resistance to venetoclax via inhibition of Bim in t(8;21)-positive acute myeloid leukemia.

Journal: Cell communication and signaling : CCS

Published: October 21, 2025

Pediatric-inspired regimen abrogates the poor prognosis of adult early T-cell precursor acute lymphoblastic leukemia.

Pediatric-inspired regimen abrogates the poor prognosis of adult early T-cell precursor acute lymphoblastic leukemia.

Journal: Leukemia & lymphoma

Published: October 16, 2025

Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML.

Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML.

Journal: Experimental hematology & oncology

Published: October 14, 2025

Author Correction: PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.

Author Correction: PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.

Journal: Nature cell biology

Published: August 19, 2025

GZMK-expressing tissue-resident memory CD8+ T cells participate in human intestinal acute graft-versus-host disease.

GZMK-expressing tissue-resident memory CD8+ T cells participate in human intestinal acute graft-versus-host disease.

Journal: JCI insight

Published: August 14, 2025

Current scenario of allogeneic hematopoietic stem cell transplantation in adult patients with relapsed/refractory acute myeloid leukemia: a narrative review.

Current scenario of allogeneic hematopoietic stem cell transplantation in adult patients with relapsed/refractory acute myeloid leukemia: a narrative review.

Journal: Annals of hematology

Published: July 24, 2025

Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

Journal: Biomarker research

Published: June 24, 2025

Increased EBV infection and relapse following haploidentical hematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis: a propensity score matching analysis.

Increased EBV infection and relapse following haploidentical hematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis: a propensity score matching analysis.

Journal: Frontiers in cellular and infection microbiology

Published: June 02, 2025

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.

Journal: Experimental hematology & oncology

Published: April 22, 2025

Showing 1-12 of 115

Last Updated: 09/26/2026